Evidence map›Paper›PMID 30582697›Full record

ArticleACS infectious diseases2019

Investigations into the Mechanism of Action of Sublancin.

Chunyu Wu, Subhanip Biswas, Chantal V Garcia De Gonzalo, Wilfred A van der Donk

Abstract read
In one paragraph

Article in ACS infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Characterization of a novel glycocin from a thermophile.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Characterization of S-glycosylated glycocins containing three disulfides.Journal of industrial microbiology & biotechnology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Saudi journal of biological sciences · 2022
    Article
  15. AntimicrobialAntibiotics (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. The life cycle of SPβ and related phages.Archives of virology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chantal V Garcia De Gonzalo
Wilfred A van der DonkORCID 0000-0002-5467-7071

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Antimicrobial resistance is a global threat that poses a rising concern. One underlying challenge is the limited number of targets in bacteria affected by the current pool of antibiotics. To potentially help find new targets, we studied a member of the class of antimicrobial natural products named glycocins. We examined the mode of action of sublancin, which contains an unusual and essential glucosylated Cys residue, by monitoring macromolecular synthesis. Sublancin negatively affected DNA replication, transcription, and translation without affecting cell wall biosynthesis. In addition, we confirmed that the presence of the PTS sugar glucose in the medium negatively impacted antimicrobial activity of sublancin. Additionally, sublancin analogues carrying different sugars retained their antimicrobial activity regardless of which sugar was attached to the peptide or the carbon source used. These data suggest a novel mechanism upstream of transcription and translation and are consistent with previous studies suggesting that the glucose uptake system is involved.

Indexed as

Anti-Bacterial AgentsBacillus subtilisBacterial ProteinsBacteriocinsGlycopeptidesMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsBacteriocinsGlycopeptidesantibioticbacteriocinglycocinglycopeptideRiPP

Identifiers

PMID30582697
PMCPMC6408254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.